These findings offer new insights into the underlying transcriptional circuitry of psoriasis lesions, and demonstrate how sequence-specific TF/uDBP-DNA interactions can be exploited to support dODN drug development and enhance interpretation of non-coding GWAS signals. Here, TF is linked to psoriasis.